Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• Insight & Intelligence™

• More »

• Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?
  November 28, 2011
  Given that the firm with the most money has just quit, questions about how to succeed are rampant.

• GEN News Highlights

• More »

• BioTime to Acquire Xennex for Its GeneCards, PanDaTox Databases
  
• BioTime Licenses Technology for Gene Underlying Cancer and Stem Cell Reprogramming
  
• BioTime Gains Option to Use USCN Cell Lines in Cancer Dx Development
  
• BioTime Taps Cornell University Technology for hESC-Derived Vascular Cells
  
• BioTime and XenneX Establish LifeMap to Generate Database of Stem Cell Lineages
  

• New Products

• More »

BioTime 3D Cell Culture Prep The HyStem-C Stiffness Sampler Trio kit contains hyaluronan-based, synthetic extracellular matrices that can conveniently screen for the perfect in vitro environment for stem cells to proliferate. The Glycosan-branded kit contains three hydrogels o